Showing results (1-10 of 63) with videos related to
Sort By:
Pageof 7
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 25, 2003
[Suicide gene therapy for prostate cancer--update of current development]Shin Ebara, Yasutomo NasuNihon Rinsho. Japanese Journal of Clinical Medicine|June 23, 2004
[Adenovirus-mediated interleukin-12 gene therapy for prostate cancer]Yasutomo Nasu, Shin Ebara, Hiromi KumonActa Medica Okayama|September 19, 2022
Molecular-targeted Therapy for Metastatic Renal Cell Carcinoma As First-line Therapy: A Single Institution 13-year ExperienceKensuke Bekku, Takuji Tsugawa, Kazuma Tsuboi, et al.Journal of Surgical Case Reports|February 18, 2022
Mesenteric desmoid tumor after robot-assisted laparoscopic cystectomy with bladder replacement: a case reportSotaro Fukuhara, Masanori Yoshimitsu, Takuya Yano, et al.Acta Medica Okayama|June 29, 2017
Diagnostic Ureteroscopy for Cases Clinically Suspected of Carcinoma in Situ of the Upper Urinary TractKatsumi Sasaki, Koichiro Wada, Motoo Araki, et al.Acta Medica Okayama|February 21, 2014
A rare complication: misdirection of an indwelling urethral catheter into the ureterTsutomu Ishikawa, Motoo Araki, Takeshi Hirata, et al.Acta Medica Okayama|January 6, 2009
Initial report of hybrid radical prostatectomy for prostate cancer: reduced bleeding, clear vision, and secure surgical marginsTakashi Saika, Yasuyuki Kobayashi, Toyohiko Watanabe, et al.Acta Medica Okayama|April 21, 2018
The Combination of Gemcitabine, Cisplatin, and Paclitaxel as Salvage Chemotherapy for Advanced Urothelial CarcinomaTakeshi Hirata, Masanori Hanamoto, Kazuma Ogura, et al.Journal of Radiation Research|March 16, 2016
Comparison of implant quality between intraoperatively built custom-linked seeds and loose seeds in permanent prostate brachytherapy using sector analysisNorihisa Katayama, Mitsuhiro Takemoto, Atsushi Takamoto, et al.The Prostate|December 6, 2005
Time course of serum testosterone and luteinizing hormone levels after cessation of long-term luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancerHaruki Kaku, Takashi Saika, Tomoyasu Tsushima, et al.Pageof 7